API OMR GLOBAL

10-Deacetylbaccatin- III Market

  • Home
  • »
  • 10-Deacetylbaccatin- III Market

10-Deacetylbaccatin- III Market Size, Share & Industry Analysis, By Grade (Crude 10-DAB III, Pharmaceutical-Grade 10-DAB III, Research-Grade 10-DAB III), End-User Industry (Pharmaceuticals, Biotechnology & Synthetic Biology, Research & Development), and Forecast, 2025-2035

The 10-Deacetylbaccatin III market is projected to experience a CAGR of approximately 3.9% during the forecast period from 2025 to 2035. This growth is largely driven by the rising demand for anticancer drugs, particularly docetaxel and paclitaxel, where 10-Deacetylbaccatin III serves as a crucial precursor. The pharmaceutical industry’s focus on developing advanced cancer treatments has led to intensified research and development activities, further driving market expansion. Geographically, China leads the market, accounting for over 35% share, attributed to its expanding pharmaceutical sector and active production of 10-Deacetylbaccatin III. North America and Europe also play a significant role in the market, driven by strict quality regulations and steady demand from the pharmaceutical industry. The increasing demand for high-purity 10-Deacetylbaccatin III is particularly notable in the synthesis of docetaxel and paclitaxel, and continues to drive market growth. The 10-Deacetylbaccatin III market report provides an in-depth analysis of market trends, pricing, production, and trade insights for this essential pharmaceutical intermediate compound. 10-Deacetylbaccatin III is widely used in the pharmaceutical industry, making it a key ingredient in global markets.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
    • Overview of 10-Deacetylbaccatin-III
    • Key Applications & Industry Use Cases
    • Market Scope & Study Objectives
  2. Market Overview
    • Global Market Size & Growth Trends (Historical & Forecast)
    • Market Value & Revenue Analysis
    • Demand-Supply Dynamics
  3. Segmental Outlook
    • By Grade
      • Crude 10-DAB III
      • Pharmaceutical-Grade 10-DAB III
      • Research-Grade 10-DAB III
    • Key End-Use Industries
      • Pharmaceuticals
      • Biotechnology & Synthetic Biology
      • Research & Development
  4. Price Analysis
    • Current Price Trends (Per kg & Per Ton)
    • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
    • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  5. Production & Supply Volume
    • Global Production Capacity & Key Manufacturers
    • Production Process & Technological Developments
    • Raw Material Analysis
  6. Trade Analysis (Import & Export)
    • Major Exporting & Importing Countries
    • Trade Volume & Value Statistics
    • Impact of Trade Regulations & Policies
  7. Regional Analysis
    • North America (US and Canada)
    • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
    • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
    • Rest of the World (Latin America and Middle East and Africa)
  8. Competitive Landscape
    • Top Global Manufacturers & Market Share
    • Company Profiles & Key Developments
    • Mergers, Acquisitions & Investments
  9. Regulatory & Compliance Factors
    • FDA, REACH, and Other Regulatory Frameworks
    • Environmental & Safety Considerations
    • Emerging Policies Impacting Market Growth
  10. Conclusion & Strategic Recommendations
    • Key Takeaways for Stakeholders
    • Market Entry Strategies
What is 10-Deacetylbaccatin III?
10-Deacetylbaccatin III is a natural diterpenoid compound derived primarily from the needles of Taxus (yew) species. It is a critical precursor used in the semi-synthesis of anti-cancer drugs, especially paclitaxel (Taxol), which is widely used in the treatment of ovarian, breast, and lung cancers.
What is the market growth of 10-Deacetylbaccatin III?
The 10-Deacetylbaccatin III market is expected to grow at a CAGR of 3.9% from 2025 to 2035, driven by the rising demand for paclitaxel-based chemotherapeutic agents and advancements in plant extraction and semi-synthetic methods.
What are the drivers of the 10-Deacetylbaccatin III Market?
Key drivers include: Major factors driving the market growth include the rising incidence of cancer worldwide, increasing preference for plant-derived oncology APIs, technological advancements in extraction processes, and growing research into paclitaxel derivatives and biosimilars.
Who are the key players operating in the 10-Deacetylbaccatin III Market?
Prominent players include: Indena S.p.A, Cipla Ltd., TCI Chemicals, Phytowelt GreenTechnologies GmbH, Alchem International, Phyton Biotech.
Which region would exhibit the fastest growth in the 10-Deacetylbaccatin III Market?
Asia-Pacific is projected to witness the fastest growth during 2025–2035, owing to expanding pharmaceutical manufacturing in India and China, availability of Taxus species, and cost-effective production capabilities.
$2500/- Single User License
$4000/- Multi User License
$5500/- Corporate License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.